MedTech

Dissect policies impacting pricing, reimbursement, and access to innovative devices in China.
Oct
02
Capitalizing on Specialized Medical Services in China: Opportunities for Innovative Life Sciences Manufacturers

Capitalizing on Specialized Medical Services in China: Opportunities for Innovative Life Sciences Manufacturers

To take advantage of these opportunities, manufacturers must focus on three key success factors.
6 min read
Aug
28
Three Key Trends Shaping Pricing for Innovative Non-VBP Medical Devices in China

Three Key Trends Shaping Pricing for Innovative Non-VBP Medical Devices in China

Understanding and strategically applying these trends is crucial for optimizing pricing strategies and enhancing market adoption of innovative medical technologies in China.
7 min read
Jul
10
5 Trillion-Yuan Equipment Renewal and China's National Quota System for Large Medical Equipment

5 Trillion-Yuan Equipment Renewal and China's National Quota System for Large Medical Equipment

In China, large medical equipment is managed through a planned allocation and permit system. Medical institutions must follow specific plans, meet clinical and functional requirements, and have the necessary technical infrastructure and qualified staff.
4 min read
Jun
19
Shanghai Pilots: Leading Value-Based and Risk-Sharing Reimbursement for Medical Consumables in China

Shanghai Pilots: Leading Value-Based and Risk-Sharing Reimbursement for Medical Consumables in China

Shanghai utilizes value-based pricing negotiations and performance-linked payments for medical consumable reimbursements, providing insights into the future direction of high-value medical consumable reimbursement under China's basic medical insurance.
7 min read
May
01
Advancements in China's BMI Payment Policies for High-Value Medical Consumables: How MedTech Should Prepare

Advancements in China's BMI Payment Policies for High-Value Medical Consumables: How MedTech Should Prepare

These policies create a national framework for the pricing and reimbursement of high-value medical consumables under basic medical insurance schemes, necessitating proactive preparedness from MedTech firms.
6 min read